How does artificial intelligence (AI) rank in the minds of pharmaceutical executives? How important is it in their eyes, and how does it compare to other trends?
With health technology assessment organisations becoming more powerful in Europe, and huge public scrutiny on drug prices in the US, it’s vitally important that pharma companies start thinking abo
Aurora’s Siân Hurst and Chris Bath explain how using data-driven insights to build comms programmes can lead to more impactful outcomes for clients and patients
It’s fair to say that pharma sales & marketing is under more pressure than ever before, with monumental changes across the industry forcing marketers and sales forc
Behavioural science provides a roadmap to understanding how HCPs make decisions and what drives prescribing behaviour, but also, more importantly, it gives us strategies that we can apply t
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.